Brief: Interpace Biosciences Files Non-Timely 10-Q With U.S. SEC
Nov 17 (Reuters) - Interpace Biosciences Inc IDXG.O :
* INTERPACE BIOSCIENCES INC FILES NON-TIMELY 10-Q WITH U.S.
SEC
* INTERPACE BIOSCIENCES - EVALUATING IMPAIRMENT OF CARRYING
VALUE
OF BARRETT INTANGIBLE ASSET, WHETHER ADJUSTMENTS TO RECORDED
AMORTIZATION EXPENSE MAY BE REQUIRED
Source : (https://bit.ly/3nCZmI5)
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million